oxaliplatin
Showing 26 - 50 of 2,879
Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)
Not yet recruiting
- Gastric Cancer Stage IV
- Oxaliplatin
- +5 more
- (no location specified)
Nov 13, 2022
Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)
Recruiting
- Gastric Cancer
- +10 more
- Docetaxel
- +3 more
-
Kyiv, UkraineNational Cancer Institute
Aug 31, 2023
Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent
Completed
- Gastroesophageal Junction Adenocarcinoma
- Oxaliplatin; Capecitabine
- Oxaliplatin; Capecitabine; concurrent radiotherapy
-
Shijiazhuang, Hebei, ChinaDepartment of General Surgery
Feb 4, 2022
Hepatocellular Carcinoma Trial in Guangzhou (Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin
Recruiting
- Hepatocellular Carcinoma
- Raltitrexed, oxaliplatin (SALOX) treatment
- Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
May 17, 2022
Peripheral Neuropathy, Colorectal Cancer Trial in Vejle (Fish oil, Corn oil)
Recruiting
- Peripheral Neuropathy
- Colorectal Cancer
- Fish oil
- Corn oil
-
Vejle, DenmarkDeparment of Oncology, Vejle Hospital
Aug 8, 2022
Stage III Colon Cancer Trial in France (Oxaliplatin, Oxaliplatin LBM)
Active, not recruiting
- Stage III Colon Cancer
- Oxaliplatin
- Oxaliplatin LBM
-
Marseille, Bouches Du Rhône, France
- +10 more
Aug 2, 2022
Gastric Cancer Trial in Beijing (S-1, Trastuzumab, Oxaliplatin)
Completed
- Gastric Cancer
- S-1
- +3 more
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences
Aug 14, 2022
Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)
Recruiting
- Colonic Neoplasms
- +2 more
- Tislelizumab
- +3 more
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital of Guangxi Medical University
Nov 9, 2023
Gastric Cancer Trial in Xi'an (Nab-paclitaxel combined with oxaliplatin and S-1)
Recruiting
- Gastric Cancer
- Nab-paclitaxel combined with oxaliplatin and S-1
-
Xi'an, ChinaThe First Affiliated Hospital of the Air Force Medical Universit
Jul 13, 2022
Oncology Trial (Duloxetine, Gabapentin, Lacosamide)
Not yet recruiting
- Oncology
- Duloxetine
- +2 more
- (no location specified)
Aug 19, 2022
Liver Metastases Trial in Hangzhou (Tislelizumab in Combination with Oxaliplatin and Tegafur)
Recruiting
- Liver Metastases
- Tislelizumab in Combination with Oxaliplatin and Tegafur
-
Hangzhou, Zhejiang, Chinagastrointestinal department of second affiliated hospital of Zhe
Jan 31, 2023
Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)
Not yet recruiting
- Advanced Colorectal Cancer
- Bevacizumab combined with Oxaliplatin and TAS-102
- (no location specified)
May 16, 2022
ADjuvant chemotherAPy After Curative Intent resecTion of
Recruiting
- Ampullary Adenocarcinoma
-
Brescia, BS, ItalyFondazione Poliambulanza
Oct 3, 2023
Tislelizumab, Bevacizumab, Oxaliplatin Trial in Beijing (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)
Recruiting
- Tislelizumab
- +7 more
-
Beijing, ChinaLin Yang
Jul 21, 2023
Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Houston (Tecentriq 1200 MG in 20 ML Injection +
Not yet recruiting
- Stage I Colon Cancer
- +2 more
- Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
- +2 more
-
Houston, TexasBaylor College of Medicine
May 22, 2023
Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in Beijing (Q-1802 Injection,Oxaliplatin Injection,Capecitabine)
Recruiting
- Gastroesophageal Junction (GEJ) Adenocarcinoma
- Q-1802 Injection,Oxaliplatin Injection,Capecitabine
-
Beijing, Beijing, ChinaBeijing cancer hospical
Jul 27, 2023
Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo
Not yet recruiting
- Colorectal Adenocarcinoma
- +2 more
- Nivolumab
- Oxaliplatin
-
Trondheim, Trondelag, Norway
- +2 more
Aug 15, 2022
Acetylcarnitine, Chemo-induced Peripheral Neuropathy Trial in Guangzhou (Acetyl-L-carnitine)
Not yet recruiting
- Acetylcarnitine
- Chemotherapy-induced Peripheral Neuropathy
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University/The First School o
Oct 28, 2022
Advanced Biliary Tract Carcinoma Trial in Hangzhou (Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur)
Not yet recruiting
- Advanced Biliary Tract Carcinoma
- Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur
-
Hangzhou, Zhejiang, Chinathe First Affiliated Hospital, School of Medicine, Zhejiang Univ
Jul 6, 2022
Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)
Recruiting
- Hepatocellular Carcinoma Resectable
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Mar 1, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)
Active, not recruiting
- Elderly Metastatic Colorectal Cancer Patients
- Capecitabine
- +2 more
-
Padua, ItalyIstituto Oncologico Veneto IRCCS
Mar 30, 2022
Gastric Adenocarcinoma Trial in Beijing (Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1)
Recruiting
- Gastric Adenocarcinoma
- Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 27, 2022
Colorectal Cancer Trial in Guangzhou (FOLFOX , FOLFIRI or FOLFOXIRI regimens, FOLFOX regimen)
Not yet recruiting
- Colorectal Cancer
- FOLFOX , FOLFIRI or FOLFOXIRI regimens
- FOLFOX regimen
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 26, 2023